Diasorin Ltd
COMPANY INFORMATION
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
DIA-MHRA Global Summit
Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026
UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026
The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026
UK NEQAS webinar: Epigenetics
Online
1 December, 2026
Weqas Annual POCT Conference 2026
London, Venue - TBC
8-9 December, 2026
UK NEQAS webinar: Fresh Muscle Biopsies
Online
8 December, 2026